At a glance
ClinicalIndex Comparison RecordN/ACompleted· 62 enrolled
Drug / intervention
Erchonia(r) ML Scanner (MLS) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Evaluation of the Effectiveness of the Erchonia ML Scanner (MLS) as a Non-invasive Dermatological Aesthetic Treatment for the Reduction of Circumference of the Upper Arms Clinical Study
In Brief
A clinical study evaluating Erchonia(r) ML Scanner (MLS) and inactive placebo laser device for Body Contouring. Completed, enrolled 62 participants.
Detailed Summary
The purpose of this study is to determine if the Erchonia® ML Scanner (MLS) low level light laser device can help to reduce the circumference of the upper arms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBody Contouring
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2011
First PostedJun 2011
Primary CompletionJan 2012
TodayJul 2026
First PostedJun 20, 2011
Enrollment StartMar 1, 2011
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 15.0 years ago
Interventions
Erchonia(r) ML Scanner (MLS)device
The Erchonia ML Scanner (MLS) low level laser light therapy device is administered to both arms for 20 minutes each, 6 times across 2 weeks.
inactive placebo laser devicedevice
non-therapeutic light application